Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis
Authors:
- Konrad ReinhartKRKonrad Reinhart
- Matthias KohlMKMatthias Kohl
- Björn KabischBKBjörn Kabisch
- John MarshallJMJohn Marshall
- Yasser SakrYSYasser Sakr
- Michael BauerMichael Bauer
- Christiane HartogCHChristiane Hartog
- Daniel SchwarzkopfDSDaniel Schwarzkopf
- Niels RiedemannNRNiels Riedemann
- 1 September 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 40 (9) , 2543-2551
Abstract
To assess shock reversal and required fluid volumes in patients with septic shock. Prospective before and after study comparing three different treatment periods. Fifty-bed single-center surgical intensive care unit. Consecutive patients with severe sepsis. Fluid therapy directed at preset hemodynamic goals with hydroxyethyl starch (predominantly 6% hydroxyethyl starch 130/0.4) in the first period, 4% gelatin in the second period, and only crystalloids in the third period. Main outcome was time to shock reversal (serum lactate 70 mm Hg; ScvO2 8 mm Hg. Safety outcomes were acute kidney injury defined by Risk, Injury, Failure, Loss, and End-stage kidney disease criteria and new need for renal replacement therapy. Hemodynamic measures, serum lactate, and creatinine were comparable at baseline in all study periods (hydroxyethyl starch n = 360, gelatin n = 352, only crystalloids n = 334). Severity scores, hospital length of stay, and intensive care unit or hospital mortality did not differ significantly among groups. All groups showed similar time to shock reversal. More fluid was needed over the first 4 days in the crystalloid group (fluid ratios 1.4:1 [crystalloids to hydroxyethyl starch] and 1.1:1 [crystalloids to gelatin]). After day 5, fluid balance was more negative in the crystalloid group. Hydroxyethyl starch and gelatin were independent risk factors for acute kidney injury (odds ratio, 95% confidence interval 2.55, 1.76-3.69 and 1.85, 1.31-2.62, respectively). Patients receiving synthetic colloids received significantly more allogeneic blood products. Shock reversal was achieved equally fast with synthetic colloids or crystalloids. Use of colloids resulted in only marginally lower required volumes of resuscitation fluid. Both low molecular weight hydroxyethyl starch and gelatin may impair renal function.Keywords
This publication has 31 references indexed in Scilit:
- Mortality after Fluid Bolus in African Children with Severe InfectionNew England Journal of Medicine, 2011
- Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care unitsCritical Care, 2010
- Lactate Clearance vs Central Venous Oxygen Saturation as Goals of Early Sepsis TherapyA Randomized Clinical TrialJAMA, 2010
- Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemiaIntensive Care Medicine, 2010
- Bundled care for septic shock: An analysis of clinical trials*Critical Care Medicine, 2010
- The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsisIntensive Care Medicine, 2010
- Hydroxyethyl StarchesAnesthesiology, 2009
- Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion modelCritical Care, 2009
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Volume Expansion with Albumin Compared to Gelofusine in Children with Severe Malaria: Results of a Controlled TrialPLoS Clinical Trials, 2006